Exponent Q1 revenue up 14% to $166.3M; EPS $0.59; declares $0.31 dividend, adds $50M buyback

EXPONENT INC

2026-Q1 EPS reported $0.59 revenue$166,303,000

Revenue before reimbursements $151.8M (+10% YoY); net income $29.6M ($0.59 diluted EPS) vs $26.7M ($0.52).
EBITDA $43.1M (28.4% of net rev) vs $37.5M (27.3%) in prior year; 76% utilization.
Engineering & scientific segment +12% YoY driven by AI consumer electronics studies and utility risk mgmt; env/health +2%.
Q2 guidance: revenue growth high-single digits; EBITDA margin 27.0%-27.8%; FY2026 outlook maintained.
Dividend $0.31/share payable June 18; additional $50M buyback authorization, total ~$67.7M available.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

EXPONENT INC reported first quarter of fiscal year 2026 ended April 3, 2026 results: revenue $166.3 million, net income $29.6 million, EPS $0.59 per diluted share. Guidance reaffirmed.

Period: first quarter of fiscal year 2026 ended April 3, 2026
Revenue: $166.3 million
Net income: $29.6 million
EPS: $0.59 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Total revenues and revenues before reimbursements for the first quarter of 2026 increased 14% to $166.3 million and 10% to $151.8 million, respectively, as compared to $145.5 million and $137.4 million in the first quarter of 2025. Net income increased to $29.6 million, or $0.59 per diluted share, in the first quarter of 2026, as compared to $26.7 million, or $0.52 per diluted share, in the same period of 2025.

View on SEC.gov

1435 earnings releases filed in the last 30 days. Browse all earnings releases →

EXPONENT INC filing history →

Source: SEC EDGAR

accession 0001171843-26-002896

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.